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Background: Vitamin D exerts profound effects on both adaptive and innate immune   functions 
involved in the development and course of autoimmune and inflammatory diseases. As the 
incidence of vitamin D insufficiency is surprisingly high in the general population, experimental 
studies have started to investigate whether vitamin D levels (measured as serum 25 hydroxy 
vitamin D-25[OH]D) are correlated with immune cells and clinical parameters.
Purpose: The aim of the present research was to investigate serum vitamin D status in a case-
control study in children with asthma and to study associations between vitamin D levels and 
certain immunological parameters.
Materials and methods: A case control study of thirty-nine children with clinically controlled 
asthma was enrolled to assess the relationship between serum vitamin D concentrations and dis-
ease activity. Vitamin D was assayed with a radioimmunoassay kit. We evaluated the relationship 
between vitamin D concentrations and forced vital capacity (FVC), forced expiratory volume 
in 1 second (FEV1), and the FEV1/FVC ratio. Correlations between inflammatory mediators, 
Th1, Th2, Th17, and regulatory T cells (Treg) and vitamin D were investigated.
Results: Only 15.38% of our asthmatic children had a sufficient serum 25(OH)D ($30 ng/mL) 
whereas 80% of healthy children expressed sufficient levels. Deficient values of vitamin D 
(,20 ng/mL) were observed in 17 (43.59%) asthmatic patients (14.40 ± 3.30 ng/mL; P = 0.0001). 
Deficiency was not observed in controls. Th1/Th2 ratio was significantly correlated to 25(OH)
D level (r = 0.698; P = 0.0001). A significant negative correlation was observed between serum 
interleukin-17 and vitamin D levels in young   asthmatics (r = −0.617; P = 0.001). A significant 
correlation was observed between CD25+Foxp3+ Treg cells and vitamin D values in asthmatics 
(r = 0.368; P = 0.021).
Conclusion: Even in a southern Mediterranean country, hypovitaminosis D is frequent in 
children with asthma. Our findings suggest that vitamin D is an important promoter of T cell 
regulation in vivo in young asthmatics.
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Introduction
Vitamin D deficiency is currently associated with asthma.1–4 The protective effects of 
vitamin D in asthma could be attributable to its immunomodulatory properties.5 Beyond 
a central role in calcium and bone physiology, vitamin D metabolism, specifically the 
conversion of 25(OH)D to the active form of vitamin D (1,25[OH]2D), has effects 
on epithelial cell, T-cell, B-cell, and dendritic cell functions, which are important 
for innate and adaptive immunity.6,7 Among the vitamin D-stimulated processes that 
contribute to tolerance are induction of tolerogenic dendritic cells,7,8 development of   
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CD4+CD25+Foxp3+ regulatory T (Treg) cells,7 activation of 
T-cell and antigen receptor signalling,8 and elaboration of anti-
inflammatory cytokines, including interleukin-10 (IL-10).9 
Gene expression profiles of dendritic cells have identified 
many 1,25(OH)2D-regulated transcripts that are central to 
dendritic cell function.7 The observation that 1,25(OH)2D-
treated human dendritic cells have the capacity to convert 
CD4 T cells into IL-10-secreting Treg cells and suppress the 
proliferation of T cells is particularly provocative in light of 
the clinical importance of CD4+CD25+Foxp3+ Treg cells.10 
Vitamin D has the ability to establish   homeostasis between 
regulatory and suppressor T cell functions to modulate inflam-
matory process as reported by Chambers and Hawrylowicz.11 
The active form of vitamin D, ie, 1,25(OH)2D3, mediates a 
shift of antigen-presenting cells (APC) and CD4+ T cells 
to a less inflammatory profile.6 Recently, it was shown that 
1,25(OH)2D3 significantly increased the secretion of IL-10 
and decreased the secretion of IL-6 and IL-17 by immune 
cells. 1,25(OH)2D3 also increased the expression and bio-
logical activity of indoleamine 2,3-dioxygenase, mediating a 
significant increase in the number of CD4+CD25+ Treg cells.11 
The transcriptional characteristics of CD4+ T cells in young 
asthmatics indicate that Foxp3 (Treg cells) and RORC (Th17) 
mRNA expression could be associated with the sustained 
inflammatory process in asthmatics.12
The aim of our study was to correlate serum vitamin D 
levels with asthma severity in children, and to correlate 
vitamin D levels with Th17 and Treg cells.
Materials and methods
Study subjects
Thirty-nine children with asthma (aged 6–16 years), who 
were diagnosed and classified according to Global Initiative 
for Asthma (GINA) recommendations13 and attending the 
Department of Pediatric Respiratory   Disease (Unit Research: 
  Homeostasis and Cell Dysfunction [UR/99/08-40]), 
A Mami Hospital, Ariana Hospital Tunisia between 
July 1, 2010 and August 31, 2010, were enrolled in the 
study during a planned visit. Severity was assessed before 
  treatment. All patients were on regular treatment with inhaled 
steroids. Control was assessed on clinical and functional 
criteria. Patients presenting an asthma exacerbation or suffer-
ing from comorbidities were excluded from the study. Thirty 
age and sex-matched children attending pediatric emergency 
for acute extra respiratory symptoms served as healthy 
controls (aged 6–16 years, mean 9.2; 20 males). Asthmatic 
patients were excluded.   Children suffering with other chronic 
diseases were excluded. Selection was made according to 
clinical criteria. The hospital ethical committee approved the 
study according to Global Initiative for Asthma guidelines 
as we recently reported, and the parents and children gave 
their informed consent.12,13
Vitamin D status definitions
Blood withdrawal was performed between July and August, 
2010. Immune tests and serum for vitamin D measurement 
were retrieved at the same time, and cellular assays were per-
formed on the day of blood collection. The collected serum 
was immediately shielded from direct light and stored 
at −20°C. At the end of the study, all samples were ana-
lyzed simultaneously. Serum concentrations of 25(OH)
D were assayed with a radioimmunoassay kit   (Dia-Sorin, 
Stillwater, MN). Vitamin D level values were used as a 
continuous variable and were categorized in descriptive 
analyses as desirable (or sufficient) when scores were 
at least 30 to 40 ng/mL (75 to 100 nmol/L), insufficient 
between 20 and 30 ng/mL (50 and 75 nmol/L) and deficient 
when ,20 ng/mL, as previously recommended.3,14
Lymphocytes subsets T cell phenotyping
Lymphocytes were isolated from peripheral blood drawn from 
39 asthmatic patients and 30 healthy children.   Peripheral blood 
mononuclear cells (PBMC) were isolated by Ficoll Hypaque 
gradient centrifugation (Histopaque®; Sigma Aldrich, Zwi-
jndrecht, The Netherlands). CD4+ T cells were selectively 
isolated with RosetteSep® (Stem Cell Technologies, Greno-
ble, France). The method for intracellular staining of CD4+ 
T-cell subsets has been described in detail previously.15,16 
The following monoclonal antibodies were used: fluores-
cein isothiocyanate (FITC)-labeled anti-interferon-gamma 
(anti-IFN-γ), phycoerythrin (PE)-labeled anti-IL-4, PE-
conjugated anti-IL-10 (all from BD Biosciences, San Jose, 
CA) or PE-labeled anti-IL-17 (R&D Systems, Minneapolis, 
MN). Based on intracytoplasmic staining, the phenotypes 
within CD4+ cells were determined as follows: Th1 cells, 
CD4+IFN-γ +IL-4−; Th2 cells, CD4+IFN-γ  −IL-4+; Tr1 (Type 1 
regulatory T) cells, CD4+IL10+; and Th17 cells, CD4+IL17+. 
Cell surface (CD4, CD25) and intracellular (Foxp3) staining 
was carried out on freshly isolated PBMCs from heparinized 
blood, as we reported recently.17 Lymphocytes were gated on 
the basis of their forward and side scatter properties by using 
FACSCalibur flow cytometry (Becton Dickinson, San Jose, 
CA). The data were analyzed using CellQuest software 
  (Becton Dickinson). The following reagents were used: 
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Ficoll and CD4-FITC monoclonal antibody (Sigma Aldrich, 
St Louis, MO); CD25-PC5 (Immunotech, Marseille, France); 
Foxp3-PE, clone: PCH101 (eBioscience, San Diego, CA); 
and an intracellular staining kit (eBioscience).
Plasma cytokines
Plasma IL-17, IL-6, and IL-10 concentrations were measured 
by enzyme-linked immunosorbent assay (using reagent kits 
from R&D Systems).
Statistical analysis
Since plasma cytokine concentrations were not in a Gaussian 
distribution, the Mann–Whitney rank sum test was used to 
assess the differences in cytokine concentrations in asthmatic 
patients and control subjects. The Pearson correlation test 
was used to ascertain the correlation among plasma cytokine 
  concentrations. All analyses were performed using SPSS 
statistical software for Windows (version 9.0; SPSS Inc, 
Chicago, IL). A probability of P , 0.05 was considered as 
significant. Unless otherwise specified, results in the figures 
are expressed as median (interquartile range: 25th, 75th, 
10th and 90th percentiles; the 50th percentile represents the 
median).
Results
Demographic data on patients  
and healthy controls
Data of asthmatic patients are depicted in Table 1. The 
severity of asthma in this group of patients was presented 
according to GINA guidelines. The severity of asthma was 
depicted as mild in 60.5%, moderate in 36.8%, and severe 
in 2.7%. Considering the low number of severe asthmatics, 
they were included with moderate asthmatics in the study. 
No difference was observed in the body weight between 
asthmatic children (32.7 kg; range: 26–45) and the healthy 
control group (36.8 kg; range: 29–47).
Vitamin D levels in asthmatic  
patients and healthy controls
The healthy subjects and asthmatic children do not differ in sex 
and age. There was no significant difference in mean vitamin D 
serum levels between healthy controls (23.30 ± 4.57 ng/mL) and 
patients (20.89 ± 7.51 ng/mL; P = 0.12). However, when patients 
and controls were divided according to vitamin D classes, 
significant differences were observed (Table 2).   Sufficient 
vitamin D levels (33.83 ± 3.31 ng/mL; range: 30–38 ng/mL) 
were observed in six asthmatics (15.38%). Insufficient levels 
were found in 16 (41%) patients (22.94 ± 2.94% ng/mL; range: 
20–29.2 ng/mL), and deficient values (14.40 ± 3.30 ng/mL; 
range: 9.7–19.7 ng/mL) were observed in 17 patients (43.59%). 
Healthy controls (n = 30) were either sufficient (80%) 
(31.83 ± 2.64 ng/mL; range: 30–37 ng/mL) or insufficient 
(20%) (21.20 ± 1.12 ng/mL; range: 20.8–29.8 ng/mL). 
No deficiency was observed in the controls.
Vitamin D serum concentrations 
depending on clinical data
Vitamin D level in asthmatics (sufficient, insufficient, and 
deficient) was studied according to the disease severity (mild 
and moderate/severe asthma). Patients with moderate asthma 
expressed lower vitamin D levels (14.67 ± 3.20 ng/mL) 
than mild asthmatics did (26.10 ± 5.85 ng/mL; P = 0.0001) 
(Figure 1).
Serum levels of 25(OH)D were slightly associated with 
forced vital capacity (FVC) percent predicted (r = 0.358; 
P = 0.025). Nonsignificant correlation was observed 
between percentage of forced expiratory volume in 1 second 
(FEV1) predicted and serum levels of vitamin D (r = 0.319; 
P = 0.0507). No correlation was observed between FEV1/FVC 
Table 1 Patients’ characteristics
Characteristic Data
number of subjects 39
Sex
  Male (68.4%)
Body weight (kg) 32.7 (26–45)
Age 9.8 (6–16)
Positive skin tests results 68.4%
FVC (%) 88.38 (58–112)
FEV1 (%) 92.74 (53–120)
FEV1/FVC 0.9 (0.79–1)
Passive smoking 47.3%
Severity
  Mild persistent 60.5%
  Moderate persistent 36.8%
  Severe persistent 2.7%
Abbreviations: FEV1, forced expiratory volume in 1 second; FVC, forced vital 
capacity.
Table 2 Comparison of vitamin D levels in asthmatic patients 
and controls
Vitamin D levels Patients Controls
Deficient (,20 ng/mL) 17 0
Insufficient (20–29 ng/mL) 16 6
Sufficient ($30 ng/mL) 6 24
Notes: Fisher test, P = 0.000; Chi squared test for linear trend = 30.303, P = 0.000.
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and vitamin D. No correlation was found between weight 
status and vitamin D level.
Serum concentrations  
of proinflammatory cytokines
Asthmatic patients showed higher serum IL-17 (18.5 pg/mL; 
range: 9.75–22.46) and IL-6 (14.72 pg/mL; range: 10.56–18.62) 
concentrations than healthy controls (IL-17: 10.5 pg/mL; 
range: 0.08–14.82; IL-6: 2.75 pg/mL; range: 0.02–8.43). The 
differences were statistically significant (IL-17: P = 0.001; 
IL-6: P = 0.002). There was no correlation between serum 
concentrations of IL-6 and   vitamin D levels (Figure 2A). 
A significant negative correlation was observed between 
IL-17 and vitamin D levels in young asthmatics (r = −0.617; 
P = 0.001) (Figure 2B).
intracellular cytokines Th1 and Th2  
in peripheral T helper cells
The percentage of IFN-γ-producing CD4+ Th1 cells was found 
to be significantly higher in healthy children (20.37% ± 4.4%; 
range: 10.5%–27%) than in asthmatic patients (6.62% ± 3.46%; 
range: 2.0%–13.8%; P = 0.0001) (Figure 3A). A significant 
difference was observed in the percentage of IL-4-producing 
CD4+ Th2 cells between healthy controls (0.92% ± 0.59%; 
range: 0.33%–1.9%) and asthmatics (0.617% ± 0.35%; range: 
0.21%–1.7%; P = 0.0035) (Figure 3B). The Th1/Th2 ratios of 
normal controls were significantly higher (27.26% ± 14.35%; 
range: 9.5%–27.3%) than those of asthmatic children 
(13.48% ± 8.55%; range: 2.15%–39.4%; P = 0.0001) 
 ( Figure 3C). A significant positive correlation was observed 
between 25(0H)D levels and Th1/Th2 ratios in asthmatic 
children (r = 0.698; P = 0.0001) (Figure 3D).
intracellular cytokines Tr1 and Th17,  
in peripheral T helper cells
Th17 (IL-17) and Tr1 (IL-10) by CD4+ T cells were assessed 
depending on intracellular cytokine expression. In asthmatic 
patients, the median percentage of IL-10+ cells within the CD4+ 
T cell compartment (0.50% ± 0.21%; range: 0.2%–0.95%) and 
the percentage of IL-17+ cells were decreased (1.048% ± 0.48%; 
range: 0.23%–1.8%) compared to healthy controls (IL-10+ 
cells, 1.39% ± 0.85%, range: 0.5%–3.4%; IL-17+ cells, 
0.44% ± 0.20%; range: 0.21%–0.99%; P = 0.0001).
A significant positive correlation was observed between 
serum 25(OH)D levels and the IL-10+CD4+ T cells (r = 0.428; 
P = 0.0081). No correlation was found between IL-17+CD4+ 
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cells and vitamin D levels (r = 0.123; P = 0.23). Tr1/Th17 
(IL-10 producing CD4+ cells/IL-17 producing CD4+ cells) 
ratio was significantly decreased in the asthmatic children 
compared with the healthy controls (Figure 4).
Regulatory T cells correlate  
with vitamin D level
We have recently reported that children with asthma 
expressed low percentages of Treg cells.17 Patients studied 
for their serum vitamin D levels were investigated for their 
CD4+ T cells expressing Treg cells. Treg cells were evalu-
ated in the peripheral circulation of 39 asthmatic patients. 
Regulatory cells within the CD4+ T cell compartment were 
defined as CD25highFoxp3+ cells. The median percentage of 
CD25highFoxp3+ Treg in the CD4+ T cell compartment was 
decreased (0.75% ± 0.37%; range: 0.2%–1.9%) compared 
to healthy children (2.20% ± 0.88%; range: 0.98%–3.9%; 
P = 0.0001) (Figure 5A). A significant correlation was 
observed between the percentage of CD25highFoxp3+ 
Treg cells and vitamin D values in asthmatics (r = 0.368; 
P = 0.021) (Figure 5B). The asthmatic children, whatever 
their vitamin D value, expressed decreased Treg cells 
compared with the healthy children (2.64% ± 0.28%; 
P = 0.0028). A significant positive correlation was observed 
between vitamin D and IL-10 levels in asthmatics (r = 0.428; 
P = 0.008).
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Note: Mann–Whitney rank sum test assessed the differences between controls and patients.
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Discussion
Contrasting levels of vitamin D have been found in   asthmatics. 
In our report, 43% of asthmatics were deficient, and 41% have 
insufficient vitamin D levels. The decrease in vitamin level 
was associated with the severity of the disease.
In agreement with a previous observation of Black and 
Scragg,18 the data from our study confirm that serum 25-OH 
vitamin D is significantly and positively correlated with FVC. 
No correlations were observed with FEV1 or FEV1/FVC. 
Recently, Zosky et al reported that vitamin D deficiency 
decreased lung functions.19 Similarly, Li et al reported 
that vitamin D deficiency was highly prevalent in Chinese 
asthma patients, and vitamin D status was correlated with 
lung function.1
The results for the asthmatic subjects in this study were 
in accord with those reported by Chinellato et al, who found 
that hypovitaminosis D is frequent in children with asthma 
who live in a Mediterranean country and that lower levels 
of vitamin D are associated with reduced asthma control.2 
Vitamin D insufficiency was also reported to be common 
in a population of North American children with mild- 
to-moderate persistent asthma and is associated with higher 
odds of severe exacerbation over a 4-year period.4
This is the first study to investigate the correlation 
between vitamin D status and the composition of the T cell 
compartment in vivo in asthmatic patients. Treg cells in the 
peripheral blood of asthmatic patients were significantly 
correlated with vitamin D status. The decreased Th1/Th2 
ratio reflected a skewing of the IFN-γ/IL-4 balance. Our data 
indicate that low serum 25(OH)D levels are associated with 
elevated inflammatory mediators and less regulated T cell 
compartments in asthmatic patients.
Several studies suggested that vitamin D deficiency could 
lead to immune malfunctioning.19,20 Although the exact mecha-
nisms of lower vitamin D levels in chronic inflammatory states 
are not yet elucidated in asthma, this deficit probably interferes 
with immunoregulatory functions of vitamin D. Immune cells 
(T and B lymphocytes, macrophages and dendritic cells) 
express vitamin D receptors (VDR) and are affected by vitamin 
D deficiency during their maturation process.
Disturbances in vitamin D homoeostasis may contribute 
to the inflammatory process in asthma. Th1, Th2, and Treg 
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cells have been shown to express the vitamin D receptor 
and to be vitamin D targets.21–23 The development of certain 
immune cells requires the expression of VDR both intrinsi-
cally and extrinsically as reported by Yu and Cantorna and 
Maruotti and Cantatore.24,25 Recently, the effect of vitamin D 
on innate immunity-mediated inflammation, enhancing the 
antimicrobial properties of immune cells, such as monocytes 
and macrophages, has been demonstrated.24,25 In addition, 
vitamin D directly affects T cell responses by inhibiting the 
production of Th1 cytokines (IL-2 and IFN-γ), Th17 cyto-
kines (IL-17), and by stimulating Th2 cytokine production 
(IL-4). Moreover, vitamin D influences the maturation of 
dendritic cells.22 In asthma, vitamin D could be considered 
an important mediator, in which fluctuation is correlated to 
the inflammatory state of the disease.
VDR may function as a regulator of asthma and atopy 
susceptibility.26 A strong association between genetic vari-
ants at the VDR locus and asthma/atopy in a Quebec cohort 
was reported.27 Along with other known asthma risk genes 
such as ADAM33,27 TLR,28 and RANTES,29 the addition 
of VDR involvement in the understanding of asthma/atopy 
pathogenesis will shed light on better control and   treatment. 
  VDR-deficient mice failed to develop experimental aller-
gic asthma, suggesting a role for vitamin D in driving 
Th2 inflammation in the airways.30
In asthmatic patients, T cells and particularly CD4+ 
  lymphocytes are stimulated and switch from naïve to 
memory CD4+ T cells.7 The decreased level of vitamin D in 
asthma could be explained in part by CD4 cells consuming 
intrinsic vitamin D during their activation, as VDR expres-
sion on CD4+ T lymphocytes increases drastically after cell 
activation.23 Addition of 1,25(OH)2D3 leads to decreased 
secretion of IL-2 and IFN-γ by CD4 T cells and promotes 
IL-5 and IL-10 production, which further shifts the T cell 
response towards Th2 dominance.23,24 Importantly, immune 
cells are able to activate vitamin D locally, which indicates 
an autocrine or paracrine role for this vitamin within the 
immune system.
Lower levels of vitamin D in children were associ-
ated with increased markers of asthma severity.4 Several 
studies have reported associations of low vitamin D status 
with poor pulmonary function and increased incidence 
of respiratory infections, asthma, and chronic obstructive 
pulmonary disease.6 Mechanistic studies suggested that 
1,25-(OH)2D3 influenced downregulation of the glucocor-
ticoid receptor by its ligand.31,32 These studies suggest that 
vitamin D may have therapeutic potential in severe asthma 
patients as a steroid-enhancing agent. Emerging studies show 
an association between low vitamin D status and poor clini-
cal responsiveness to glucocorticoids in asthma patients.33 
If a steroid-enhancing role for vitamin D is proven, it is likely 
to be applicable to other chronic illness in which steroids 
represent a primary treatment, as also suggested by data on 
animal models.32 Nevertheless, considerable interest remains 
in the therapeutic application of vitamin D to asthma, and 
examples of beneficial effects exist.
The fact that Th1/Th2 ratio and Th17 were correlated to 
serum vitamin D raises a question about the origin of vitamin 
D deficiency in asthma. More studies are needed to clarify the 
mechanisms by which vitamin D regulates cellular   immunity. 
Similarly, the genetic factors influencing 1,25(OH)2D3 produc-
tion and vitamin D receptor expression should be explored. 
The microbial pattern-recognition receptor known as Toll-like 
receptor 9 (TLR9) was described as a biomarker of vitamin 
D-induced IL-10+ Tregs. Ligation of TLR9 with its agonist 
CpG (cytosine-phosphate-guanine) oligonucleotide turned off 
IL-10 production, suggesting a control mechanism abrogating 
Treg.33,34 The active form of vitamin D influences innate and 
adaptive immunity. It acts on APCs and T cells to promote 
peripheral tolerance through the inhibition of inflammatory 
responses and the induction of Treg cells. Recently, Wong 
et al reported that a coculture of bronchial epithelial cells and 
basophils could significantly induce the release of IL-6, an epi-
thelial inflammatory cytokine as well as CCL2, a chemokine 
for basophils, eosinophils, and monocytes.35 This induction 
was synergistically enhanced by IL-17A. The interaction of 
basophils and bronchial epithelial cells was under IL-17A 
stimulation. It was differentially regulated by extracellular 
signal-regulated kinase, c-Jun N-terminal protein kinase, 
p38 mitogen-activated protein kinase, and nuclear factor-κB 
pathways. These findings suggest a new immunopathological 
role of Th17 cells and basophils in allergic asthma.35 Recently, 
Baeke et al reported that TX527 (hypocalcemic vitamin D 
analogs) directly affects human T cell function, thereby inhib-
iting effector T cell reactivity while inducing regulatory T cell 
characteristics, imprinting them with a specific homing sig-
nature favoring migration to sites of inflammation.36 These 
findings confirmed that   vitamin D is an important regulator 
of immune function. T cells express the vitamin D receptor 
and have been shown to be direct and indirect vitamin D 
targets.37 Cantorna37 suggested that the expression of VDR 
is required for the development of two cell types, NKT cells 
and CD8αα T cells, which inhibit autoimmunity. In addition, 
effector T cell cytokine production is regulated by vitamin D. 
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The available evidence suggests that NKT and CD8αα T cells 
express VDR as part of the selection process to protect against 
the generation of autoimmunity.37
Conclusion
Our study provides important information on vitamin D levels 
in asthmatic children in the Mediterranean region. We were 
able to show that vitamin D deficiency in asthmatic patients 
is common, and it is similar to that seen in the autoimmune 
diseases. We found significant correlations between several 
inflammatory and immunological markers and vitamin D 
levels. These findings should be confirmed prospectively 
through the generation of an efficient multivariate model 
allowing further research about the use of vitamin D supple-
mentation in patients with asthma.
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